, Sept. 20
/PRNewswire/ -- Seahorse Bioscience, Inc., the leading manufacturer of instruments and consumables for measuring cellular metabolism announced today that Chief Executive Officer, Jay Teich
, will present at the 2010 UBS Global Life Sciences Conference on Tuesday, September 21, 2010
at 4:00 p.m. EDT
at the Grand Hyatt Hotel in New York City. Mr. Teich will highlight the company's strategy for maintaining rapid growth of 85% CAGR in a new $1BB Life Science Cellular Bioenergetics market. "We believe that we are at the right place at the right time to ride a wave of interest in cell bioenergetics as it applies to Cancer, Obesity, Diabetes, Ageing and Cardiovascular function," proclaimed Mr. Teich.
A live webcast of the conference can be viewed at http://cc.talkpoint.com/ubsx001/092110a_lv/
About Seahorse Bioscience
Seahorse XF instruments are the new standard in cellular bioenergetic measurements. More than 600 scientists in 20 countries are utilizing the award-winning XF Analyzers to advance their research into the role of mitochondrial (dys)function and its implications in diseases. Founded in 2001, Seahorse is headquartered in Billerica, MA. For more information, visit http://www.seahorsebio.com.
Seahorse Bioscience, Inc.
Media Contact: Cynthia Egan
SOURCE Seahorse Bioscience, Inc.